DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aakaar Medical Technologies Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·17 Oct 2026, 9:44 am

Aakaar Medical Technologies

Aakaar Medical Technologies Limited has informed stock exchanges that it will be holding an analyst or institutional investor meet. This meeting is scheduled to be conducted in accordance with the Para A-XBRL format, a regulatory requirement for detailed disclosures. The company is expected to use this platform to present its business strategy and financial performance to potential investors and market experts.

For investors, such meetings are significant as they provide a direct opportunity to understand the company's future plans and address concerns with management. It signals the company's commitment to transparency and can offer insights into upcoming projects or market opportunities. Investors should watch for updates on the meeting's agenda and any specific announcements made by the company regarding its operational outlook.